Long-range PCR and capture sequencing methods are being applied to determine patient-specific genomic EWSR1-FLI1 breakpoints which are subsequently used to detect tumor DNA shed in the circulation by digital PCR. This evidence concerns the gene EWSR1 and neoplasm.